Kynurenines have been reported in the cancer literature to support immune escape of tumors via engagement of the PD-1/PD-L1 immune checkpoint and differentiation of CD4+ T cells into immunosuppressive Tregs (60, 61). This evidence concerns the gene CD4 and cancer.